Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)

Clinical trial NCT02589600 · COMPLETED

Trial details

NCT number: NCT02589600
Sponsor: Susan L. Greenspan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Osteoporotic Fractures Osteoporosis, Postmenopausal

Start date: 2016-01-01
Primary completion: 2022-06-22
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.